Litcius/Paper detail

Optimized allele-specific silencing of the dominant-negative COL6A1 G293R substitution causing collagen VI-related dystrophy

Astrid Brull, Apurva Sarathy, Véronique Bolduc, Grace S. Chen, Riley M. McCarty, Carsten G. Bönnemann

2024Molecular Therapy — Nucleic Acids15 citationsDOIOpen Access PDF

Abstract

gene. By intentionally introducing an additional mismatch into the siRNA design, we achieved enhanced specificity toward the mutant allele. Treatment of patient-derived fibroblasts effectively reduced the levels of mutant transcripts while maintaining unaltered wild-type transcript levels, rescuing the secretion and assembly of collagen VI matrix by reducing the dominant-negative effect of mutant chains. Our findings establish a promising treatment approach for patients with the recurrent dominantly negative acting G293R glycine substitution.

Topics & Concepts

Collagen VIMuscular dystrophyGeneticsAlleleCongenital muscular dystrophySubstitution (logic)MedicineBiologyExtracellular matrixGeneComputer scienceProgramming languageCell Adhesion Molecules ResearchRNA Interference and Gene DeliveryMuscle Physiology and Disorders
Optimized allele-specific silencing of the dominant-negative COL6A1 G293R substitution causing collagen VI-related dystrophy | Litcius